Form 4: ReposiTrak CEO Sells Shares Under 10b5-1 Plan

ReposiTrak CEO Randall K. Fields sold a total of 7,500 shares of common stock over three days in August 2025, pursuant to a pre-arranged 10b5-1 trading plan for charitable commitments.

Summary

• Randall K. Fields, Chief Executive Officer, Director, and 10% Owner of ReposiTrak, Inc. (TRAK), reported sales of common stock.
• A total of 7,500 shares of common stock were sold across three separate transactions on August 25, 26, and 27, 2025.
• The sales were executed automatically pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC.
• The trading plan was established to enable Mr. Fields to meet some of his charitable commitments.
• On August 25, 2025, 2,000 shares were sold at a weighted average price of $16.4155 per share, with prices ranging from $16.10 to $16.845.
• On August 26, 2025, 1,500 shares were sold at a weighted average price of $15.83 per share, with prices ranging from $15.68 to $15.915.
• On August 27, 2025, 4,000 shares were sold at a weighted average price of $15.8915 per share, with prices ranging from $15.44 to $16.36.
• Following these transactions, Mr. Fields' indirect beneficial ownership through RK Fields Charitable 2022, LLC decreased to 94,500 shares of common stock.
• Mr. Fields continues to hold substantial direct and indirect beneficial ownership in ReposiTrak, Inc., including 3,683,955 shares of common stock directly and additional shares indirectly through various entities and his spouse.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the small volume relative to total holdings and the explicit reason of charitable commitments under a pre-arranged 10b5-1 plan mitigate any significant negative interpretation. It does not suggest a lack of confidence in the company.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and non-discretionary approach to stock liquidation, which often mitigates concerns about insider selling.
• The stated purpose of the sales is to meet charitable commitments, which can be viewed positively regarding the reporting person's philanthropic activities.

Negatives

• The sale of common stock by a CEO and 10% owner, even under a 10b5-1 plan, represents a reduction in insider ownership, which can sometimes be perceived as a lack of confidence, though the stated reason here is charitable.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC. The Trading Plan was established to enable the Reporting Person to meet some of his charitable commitments.

Industry Context

This insider transaction report is specific to ReposiTrak, Inc. and its CEO. It does not provide information directly related to broader industry trends or competitor activities.

Related Party Transactions

• The sales were conducted by RK Fields Charitable 2022, LLC, which is managed by the Reporting Person as Trustee of the 2022 RK Fields Charitable Remainder Unitrust. This entity is considered a related party to Randall K. Fields.

Stakeholder Impact

• Shareholders: Minimal direct impact due to the relatively small volume of shares sold and the pre-planned, charitable nature of the transactions. The CEO retains substantial ownership.
• Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction report.

Key Dates

Recommendation

This Form 4 filing reports routine insider sales under a pre-arranged 10b5-1 plan for charitable purposes. The volume of shares sold is a small fraction of the CEO's total beneficial ownership. Such a transaction typically does not indicate a change in the company's fundamental outlook or warrant a shift in investment recommendation. Investors should continue to evaluate ReposiTrak based on its operational performance, financial results, and strategic initiatives rather than this specific insider transaction.

Keywords

ReposiTrak, TRAK, Randall K. Fields, Insider Sale, Form 4, 10b5-1 Plan, Beneficial Ownership, CEO, Director, Charitable Commitments